Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 6.19 M6.05 M6.37 M6.78 M8.15 M8.18 M 29.47 M Research & development —————— — Operating income 49.67 M55.52 M59.36 M59.63 M66.07 M67.03 M 252.09 M Non-Operating Income, Total 543 K561 K858 K1.33 M865 K876 K 3.93 M Interest expense, net of interest capitalized 31.79 M32.48 M33.64 M31.24 M29.52 M29.44 M 123.84 M Non-Operating Income, excl. Interest Expenses -31.25 M-31.92 M-32.78 M-29.91 M-28.66 M-28.56 M -119.91 M Unusual income/expense —————— — Pretax income 24.05 M25.96 M27.44 M26.05 M27.28 M31.18 M 111.95 M Equity in earnings —————— — Taxes 4.51 M3.34 M3.68 M3.21 M4.6 M5.25 M 16.74 M Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 19.54 M22.62 M23.76 M22.84 M22.68 M25.93 M 95.21 M Discontinued operations —————— — Net income 19.54 M22.62 M23.76 M22.84 M22.68 M25.93 M 95.21 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 19.54 M22.62 M23.76 M22.84 M22.68 M25.93 M 95.21 M Basic earnings per share (Basic EPS) 1.211.391.461.411.321.5 5.69 Diluted earnings per share (Diluted EPS) 1.211.391.461.411.321.5 5.69 Average basic shares outstanding 16.2 M16.24 M16.25 M16.24 M17.24 M17.28 M — Diluted shares outstanding 16.2 M16.24 M16.25 M16.24 M17.24 M17.28 M — EBITDA 18.84 M23.74 M26.19 M28.95 M37.7 M39.31 M 132.14 M EBIT 17.54 M22.44 M24.89 M27.65 M35.33 M36.94 M 124.81 M Cost of revenue 2.1 M1.6 M200 K-700 K-1.8 M-1.8 M -4.1 M Other cost of goods sold —————— — Depreciation & amortization (cash flow) 1.3 M1.3 M1.3 M1.3 M2.37 M2.37 M 7.33 M